Skip to main content
NCBI home page
The Ulster Medical Journal logoLink to The Ulster Medical Journal
. 1994 Apr;63(1):44–51.

Adjuvant therapy for colorectal cancer--is there a place for a Northern Ireland study?

R H Wilson 1, R F Houston 1, R J Moorehead 1
PMCID: PMC2449093  PMID: 8658995

Abstract

Survival from colorectal cancer has not improved over the last four decades despite advances in surgery and anaesthesia. The answer to the question whether adjuvant chemotherapy and radiotherapy will improve survival from the disease can only come from randomised, controlled trails. In the future, immunotherapy and gene therapy may be of benefit but these are still many years from the clinical arena. We believe that current evidence suggests that patients with Dukes B and C colorectal cancer should be entered into trials of adjuvant therapy. This evidence is reviewed below among with estimates of the impact that adjuvant therapy would have on the outcome from this disease in Northern Ireland.

Full text

PDF
44

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASTLER V. B., COLLER F. A. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg. 1954 Jun;139(6):846–852. doi: 10.1097/00000658-195406000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alberto P. Adjuvant and palliative treatments of colon cancer. Eur J Cancer. 1992;28A(4-5):924–926. doi: 10.1016/0959-8049(92)90152-r. [DOI] [PubMed] [Google Scholar]
  3. Amery W. K., Spreafico F., Rojas A. F., Denissen E., Chirigos M. Adjuvant treatment with levamisole in cancer: a review of experimental and clinical data. Cancer Treat Rev. 1977 Sep;4(3):167–194. doi: 10.1016/s0305-7372(77)80023-6. [DOI] [PubMed] [Google Scholar]
  4. Anderson P., Dische S. Local tumor control and the subsequent incidence of distant metastatic disease. Int J Radiat Oncol Biol Phys. 1981 Dec;7(12):1645–1648. doi: 10.1016/0360-3016(81)90186-3. [DOI] [PubMed] [Google Scholar]
  5. Balslev I., Pedersen M., Teglbjaerg P. S., Hanberg-Soerensen F., Bone J., Jacobsen N. O., Overgaard J., Sell A., Bertelsen K., Hage E. Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid. A randomized multicenter study. Cancer. 1986 Jul 1;58(1):22–28. doi: 10.1002/1097-0142(19860701)58:1<22::aid-cncr2820580106>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  6. Cummings B. J. Adjuvant radiation therapy for colorectal cancer. Cancer. 1992 Sep 1;70(5 Suppl):1372–1383. doi: 10.1002/1097-0142(19920901)70:3+<1372::aid-cncr2820701527>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  7. Enker W. E., Pilipshen S. J., Heilweil M. L., Stearns M. W., Jr, Janov A. J., Hertz R. E., Sternberg S. S. En bloc pelvic lymphadenectomy and sphincter preservation in the surgical management of rectal cancer. Ann Surg. 1986 Apr;203(4):426–433. doi: 10.1097/00000658-198604000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fielding L. P., Hittinger R., Grace R. H., Fry J. S. Randomised controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma. Lancet. 1992 Aug 29;340(8818):502–506. doi: 10.1016/0140-6736(92)91708-g. [DOI] [PubMed] [Google Scholar]
  9. Fisher B., Wolmark N., Rockette H., Redmond C., Deutsch M., Wickerham D. L., Fisher E. R., Caplan R., Jones J., Lerner H. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst. 1988 Mar 2;80(1):21–29. doi: 10.1093/jnci/80.1.21. [DOI] [PubMed] [Google Scholar]
  10. Grage T. B., Moss S. E. Adjuvant chemotherapy in cancer of the colon and rectum: demonstration of effectiveness of prolonged 5-FU chemotherapy in a prospectively controlled, randomized trial. Surg Clin North Am. 1981 Dec;61(6):1321–1329. doi: 10.1016/s0039-6109(16)42587-9. [DOI] [PubMed] [Google Scholar]
  11. Gunderson L. L., Sosin H. Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy. Cancer. 1974 Oct;34(4):1278–1292. doi: 10.1002/1097-0142(197410)34:4<1278::aid-cncr2820340440>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  12. Higgins G. A., Donaldson R. C., Humphrey E. W., Rogers L. S., Shields T. W. Adjuvant therapy for large bowel cancer: update of Veterans Administration Surgical Oncology Group Trials. Surg Clin North Am. 1981 Dec;61(6):1311–1320. doi: 10.1016/s0039-6109(16)42586-7. [DOI] [PubMed] [Google Scholar]
  13. Higgins G. A., Humphrey E., Juler G., LeVeen H. H., McCaughan J., Keehn R. J. Adjuvant chemotherapy in the surgical treatment of large bowel cancer. Cancer. 1976 Oct;38(4):1461–1467. doi: 10.1002/1097-0142(197610)38:4<1461::aid-cncr2820380402>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  14. Hutter R. V., Sobin L. H. A universal staging system for cancer of the colon and rectum. Let there be light. Arch Pathol Lab Med. 1986 May;110(5):367–368. [PubMed] [Google Scholar]
  15. Johnson P. W., Thompson P. I., Seymour M. T., Deasy N. P., Thuraisingham R. C., Slevin M. L., Wrigley P. F. A less toxic regimen of 5-fluorouracil and high-dose folinic acid for advanced gastrointestinal adenocarcinomas. Br J Cancer. 1991 Sep;64(3):603–605. doi: 10.1038/bjc.1991.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Krook J. E., Moertel C. G., Gunderson L. L., Wieand H. S., Collins R. T., Beart R. W., Kubista T. P., Poon M. A., Meyers W. C., Mailliard J. A. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med. 1991 Mar 14;324(11):709–715. doi: 10.1056/NEJM199103143241101. [DOI] [PubMed] [Google Scholar]
  17. Laurie J. A., Moertel C. G., Fleming T. R., Wieand H. S., Leigh J. E., Rubin J., McCormack G. W., Gerstner J. B., Krook J. E., Malliard J. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol. 1989 Oct;7(10):1447–1456. doi: 10.1200/JCO.1989.7.10.1447. [DOI] [PubMed] [Google Scholar]
  18. Metzger U. Adjuvant therapy for colorectal carcinoma. World J Surg. 1991 Sep-Oct;15(5):576–582. doi: 10.1007/BF01789201. [DOI] [PubMed] [Google Scholar]
  19. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project. J Clin Oncol. 1992 Jun;10(6):896–903. doi: 10.1200/JCO.1992.10.6.896. [DOI] [PubMed] [Google Scholar]
  20. Moertel C. G., Fleming T. R., Macdonald J. S., Haller D. G., Laurie J. A., Goodman P. J., Ungerleider J. S., Emerson W. A., Tormey D. C., Glick J. H. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990 Feb 8;322(6):352–358. doi: 10.1056/NEJM199002083220602. [DOI] [PubMed] [Google Scholar]
  21. Panettiere F. J., Goodman P. J., Costanzi J. J., Cruz A. B., Jr, Vaitkevicius V. K., McCracken J. D., Brownlee R. W., Laufman L., Stephens R. L., Bonnet J. Adjuvant therapy in large bowel adenocarcinoma: long-term results of a Southwest Oncology Group Study. J Clin Oncol. 1988 Jun;6(6):947–954. doi: 10.1200/JCO.1988.6.6.947. [DOI] [PubMed] [Google Scholar]
  22. Park J. G., Collins J. M., Gazdar A. F., Allegra C. J., Steinberg S. M., Greene R. F., Kramer B. S. Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines. J Natl Cancer Inst. 1988 Dec 7;80(19):1560–1564. doi: 10.1093/jnci/80.19.1560. [DOI] [PubMed] [Google Scholar]
  23. Pinedo H. M., Peters G. F. Fluorouracil: biochemistry and pharmacology. J Clin Oncol. 1988 Oct;6(10):1653–1664. doi: 10.1200/JCO.1988.6.10.1653. [DOI] [PubMed] [Google Scholar]
  24. Poon M. A., O'Connell M. J., Moertel C. G., Wieand H. S., Cullinan S. A., Everson L. K., Krook J. E., Mailliard J. A., Laurie J. A., Tschetter L. K. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol. 1989 Oct;7(10):1407–1418. doi: 10.1200/JCO.1989.7.10.1407. [DOI] [PubMed] [Google Scholar]
  25. Quirke P., Durdey P., Dixon M. F., Williams N. S. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986 Nov 1;2(8514):996–999. doi: 10.1016/s0140-6736(86)92612-7. [DOI] [PubMed] [Google Scholar]
  26. Rich T., Gunderson L. L., Lew R., Galdibini J. J., Cohen A. M., Donaldson G. Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer. 1983 Oct 1;52(7):1317–1329. doi: 10.1002/1097-0142(19831001)52:7<1317::aid-cncr2820520731>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  27. Scheithauer W., Rosen H., Kornek G. V., Sebesta C., Depisch D. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ. 1993 Mar 20;306(6880):752–755. doi: 10.1136/bmj.306.6880.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Taylor I., Machin D., Mullee M., Trotter G., Cooke T., West C. A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. Br J Surg. 1985 May;72(5):359–363. doi: 10.1002/bjs.1800720509. [DOI] [PubMed] [Google Scholar]
  29. Treurniet-Donker A. D., van Putten W. L., Wereldsma J. C., Bruggink E. D., Hoogenraad W. J., Roukema J. A., Snijders-Keilholz A., Meijer W. S., Meerwaldt J. H., Wijnmaalen A. J. Postoperative radiation therapy for rectal cancer. An interim analysis of a prospective, randomized multicenter trial in The Netherlands. Cancer. 1991 Apr 15;67(8):2042–2048. doi: 10.1002/1097-0142(19910415)67:8<2042::aid-cncr2820670806>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  30. Willett C. G., Tepper J. E., Cohen A. M., Orlow E., Welch C. E. Failure patterns following curative resection of colonic carcinoma. Ann Surg. 1984 Dec;200(6):685–690. doi: 10.1097/00000658-198412000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Windle R., Bell P. R., Shaw D. Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancer. Br J Surg. 1987 Jul;74(7):569–572. doi: 10.1002/bjs.1800740707. [DOI] [PubMed] [Google Scholar]
  32. Wolmark N., Fisher B., Rockette H., Redmond C., Wickerham D. L., Fisher E. R., Jones J., Glass A., Lerner H., Lawrence W. Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01. J Natl Cancer Inst. 1988 Mar 2;80(1):30–36. doi: 10.1093/jnci/80.1.30. [DOI] [PubMed] [Google Scholar]
  33. Wolmark N., Rockette H., Wickerham D. L., Fisher B., Redmond C., Fisher E. R., Potvin M., Davies R. J., Jones J., Robidoux A. Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02. J Clin Oncol. 1990 Sep;8(9):1466–1475. doi: 10.1200/JCO.1990.8.9.1466. [DOI] [PubMed] [Google Scholar]

Articles from The Ulster Medical Journal are provided here courtesy of Ulster Medical Society

RESOURCES